Cholesterol and HDL-cholesterol values in women during use of subdermal implants releasing levonorgestrel
- 1 August 1985
- journal article
- research article
- Published by Elsevier in Contraception
- Vol. 32 (2) , 163-171
- https://doi.org/10.1016/0010-7824(85)90104-0
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Release rates of levonorgestrel from silasticR capsules, homogeneous rods and covered rods in humansContraception, 1983
- Clinical chemistry in women treated with levonorgestrel implants (NORPLANT™∗∗NORPLANT™is the Population Council's trademark for subdermal implants containing levonorgestrel.) or a TCu 200 IUDContraception, 1983
- Progestogens and arterial disease—Evidence from the Royal College of General Practitioners' studyAmerican Journal of Obstetrics and Gynecology, 1982
- Oral Contraception and Some Debatable Side EffectsActa Obstetricia et Gynecologica Scandinavica, 1982
- Progestogen Effects and their Relationship to Lipoprotein Changes: A Report from the Oral Contraception Study of the Royal College of General PractitionersActa Obstetricia et Gynecologica Scandinavica, 1982
- Comparison of the metabolic effects of two hormonal contraceptive methods: An oral formulation and a vaginal ring II. Serum lipoproteins and apolipoproteinsContraception, 1981
- Oral Contraceptives and Cardiovascular DiseaseNew England Journal of Medicine, 1981
- Serum High-Density-Lipoprotein Cholesterol in Women Using Oral Contraceptives, Estrogens and ProgestinsNew England Journal of Medicine, 1978
- HDL cholesterol and other lipids in coronary heart disease. The cooperative lipoprotein phenotyping study.Circulation, 1977
- High density lipoprotein as a protective factor against coronary heart diseaseThe American Journal of Medicine, 1977